<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Amgen&#8217;s Osteoporosis Drug: Make Or Break</title>
	<atom:link href="http://www.pharmalot.com/2008/09/amgens-osteoporosis-drug-make-or-break/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/09/amgens-osteoporosis-drug-make-or-break/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 18:05:01 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Steve</title>
		<link>http://www.pharmalot.com/2008/09/amgens-osteoporosis-drug-make-or-break/#comment-372823</link>
		<dc:creator>Steve</dc:creator>
		<pubDate>Fri, 12 Sep 2008 22:08:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15481#comment-372823</guid>
		<description>I have been reading quite a few analysts reports, and they are extremely excited about next Tuesday's Deno meeting.

What is released at the meeting, will define the immediate future of Amgen.  If the news is fantastic, we will see a very nice share pop. If not, it could be a flat tire.</description>
		<content:encoded><![CDATA[<p>I have been reading quite a few analysts reports, and they are extremely excited about next Tuesday&#8217;s Deno meeting.</p>
<p>What is released at the meeting, will define the immediate future of Amgen.  If the news is fantastic, we will see a very nice share pop. If not, it could be a flat tire.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.150 seconds -->

